Russell Investments Group, Ltd. Cara Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$0.6 - $1.65 $157,358 - $432,735	-262,264 Reduced 89.27%	31,536 $23,000
Q3 2023 Nov 13, 2023	BUY	$1.67 - $3.33 $433,800 - $865,004	259,761 Added 763.13%	293,800 $493,000
Q2 2023 Aug 10, 2023	BUY	$2.83 - $4.94 $92,659 - $161,745	32,742 Added 2524.44%	34,039 $96,000
Q1 2023 May 09, 2023	BUY	$4.89 - $12.27 $6,342 - $15,914	1,297 New	1,297 $6,000
Q2 2022 Jul 29, 2022	SELL	$7.45 - $13.84 $245,447 - $455,972	-32,946 Closed	0 $0

Q1 2022 May 05, 2022	SELL	$9.94 - $12.65 $53,586 - $68,196	-5,391 Reduced 14.06%	32,946 $398,000
Q4 2021 Jan 21, 2022	SELL	$11.99 - $18.14 $150,834 - $228,201	-12,580 Reduced 24.71%	38,337 $466,000
Q3 2021 Nov 08, 2021	BUY	$11.55 - $16.06 $7,773 - $10,808	673 Added 1.34%	50,917 $786,000
Q2 2021 Aug 04, 2021	SELL	$12.38 - $29.19 $78,674 - $185,502	-6,355 Reduced 11.23%	50,244 $716,000
Q1 2021 May 10, 2021	SELL	$15.07 - $21.71 $551,004 - $793,782	-36,563 Reduced 39.25%	56,599 $1.23 Million
Q4 2020 Feb 08, 2021	BUY	$12.72 - $16.16 $372,479 - $473,213	29,283 Added 45.84%	93,162 $1.41 Million
Q3 2020 Nov 09, 2020	BUY	$12.34 - $17.92 $522,623 - $758,947	42,352 Added 196.74%	63,879 $812,000
Q2 2020 Aug 05, 2020	BUY	$12.39 - $17.33 $191,908 - $268,424	15,489 Added 256.53%	21,527 $367,000
Q3 2019 Nov 01, 2019	BUY	$18.28 - $26.91 $110,374 - $162,482	6,038 New	6,038 $110,000
Q1 2018 May 11, 2018	SELL	$11.77 - $16.08 $73,503 - $100,419	-6,245 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$12.6 - $16.34 $78,687 - $102,043	6,245	6,245 $85,000

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $17.7M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.